Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars ...

Pharma stocks rise as Cipla faces supply issues, Zydus gains FDA approval, and Biocon secures funding through a QIP.

Stocks to Watch today, January 7, 2026: Indian equities are expected to open lower on Wednesday, tracking mixed global cues.

Indian drugmaker Biocon Ltd. drew demand for about four times the shares it offered to institutional investors, with interest largely coming from local mutual funds, according to people familiar with ...

Biocon Ltd is quoting at Rs 383.95, up 1.31% on the day as on 12:49 IST on the NSE. The stock is down 2.48% in last one year as compared to a 11% jump in NIFTY and a 1.13% jump in the Nifty Pharma ...

Biotech firm Biocon on Thursday said it has raised ₹4,150 crore through a Qualified Institutions Placement (QIP) process. The initiative saw issuance of 1,12,664,585 equity shares of face value ₹5 ...

Biocon said the proceeds would be primarily used to meet the cash consideration payable to Mylan Inc, now Viatris, for the ...

Track top stocks like TCS, HCL Tech, Biocon, and Maruti Suzuki after fresh earnings and deals—get the latest market movers ...

In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg ...

Sical Logistics Ltd., KP Energy Ltd., Mazagon Dock Shipbuilders Ltd., Biocon Ltd. and ICICI Lombard General Insurance Co. are ...

The board of Biocon has approved the issue of 11.26 crore equity shares of face value of ₹5 each to eligible institutions.

Indian drugmaker Biocon Ltd drew demand for about four times the shares it offered to institutional investors, with interest ...